Search for: "Bristol, Inc." Results 101 - 120 of 509
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Jan 2007, 6:09 am
In August 2006, generic drug maker Apotex Inc. began selling a cheaper version of Plavix, a blood thinner Bristol-Myers co-markets with Sanofi-Aventis SA, after an agreement to settle a patent dispute fell apart. [read post]
27 Oct 2010, 10:38 am
Fort Wayne, Indiana - Patent lawyers for Romary Associates, Inc. of Fort Wayne, IN, filed a lawsuit alleging that Kibbi LLC d/b/a Renegade Custom Coaches and Trailers, McKibbin Enterprises, Inc., and Kibbi Incorporated, all of Bristol, IN, have infringed Patent No. 7,475,809, MOBILE BANKING VEHICLE, as issued by the U.S. [read post]
20 Aug 2021, 9:58 am by Seyfarth Shaw LLP
The Anthem Companies, Inc. that courts may not exercise specific jurisdiction over FLSA claims “unrelated to the defendant’s conduct in the forum state. [read post]
1 Sep 2015, 8:59 am by WIMS
(c)Waste Information & Management Services, Inc. [read post]
23 May 2008, 7:20 am by Ann
The Court of Appeal has now reached its decision in Actavis UK v Merck Co, Inc. [read post]
22 Mar 2011, 8:10 am by Sonya Hubbard
It also added that in 2010, Bristol-Myers Squibb’s Patient Assistance Program Foundation, Inc. and other assistance programs provided approximately $458 million worth of free medications to more than 263,000 people. [read post]
23 Feb 2017, 7:21 am by Altman & Altman
As of December 2016, approximately 34 Eliquis lawsuits were pending against the drug’s manufacturers, Bristol-Myers Squibb and Pfizer, Inc. [read post]
16 Jan 2014, 8:16 am by WIMS
Environmental Protection Agency released its final Bristol Bay Assessment describing potential impacts to salmon and ecological resources from proposed large-scale copper and gold mining in Bristol Bay, Alaska. [read post]
23 Jan 2009, 9:59 pm
By Jason Derry --Peptimmune and Novartis Sign $500 Million Deal Peptimmune Inc. and Novartis AG recently announced a licensing deal for Peptimmune's multiple sclerosis drug candidate, PI-2301. [read post]
10 Oct 2016, 12:40 pm by Tom Lamb
Sprycel (dasatinib) -- Bristol-Myers Squibb Canada Iclusig (ponatinib hydrochloride) -- ARIAD Pharmaceuticals, Inc. [read post]